Overview
Kim Kramer is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Kramer is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
Her clinical research consists of co-authoring 74 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles and participated in 1 clinical trial in the study of Medulloblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Kramer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Ira Dunkel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Brain Stem Cancer.
Memorial Pediatric Group
Matthias Karajannis is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Karajannis is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Neurofibromatosis, Glioma, Medulloblastoma, and Pineocytoma.
Stephen Gilheeney is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Gilheeney is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Sickle Cell Disease.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Embryonal Tumor with Multilayered Rosettes
- NeuroblastomaDr. Kramer isElite. Learn about Neuroblastoma.
- Distinguished
- Diffuse Midline Glioma H3 K27M-MutantDr. Kramer isDistinguished. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- Advanced
- Brain Stem CancerDr. Kramer isAdvanced. Learn about Brain Stem Cancer.
- Hereditary NeuroblastomaDr. Kramer isAdvanced. Learn about Hereditary Neuroblastoma.
- MedulloblastomaDr. Kramer isAdvanced. Learn about Medulloblastoma.
- Experienced
- Febrile NeutropeniaDr. Kramer isExperienced. Learn about Febrile Neutropenia.
- GliomaDr. Kramer isExperienced. Learn about Glioma.
- Infantile NeutropeniaDr. Kramer isExperienced. Learn about Infantile Neutropenia.
- RetinoblastomaDr. Kramer isExperienced. Learn about Retinoblastoma.
- RhabdomyosarcomaDr. Kramer isExperienced. Learn about Rhabdomyosarcoma.